04.08.2010
- Sanofi-Aventis has grabbed the headlines with its $18.4 billion bid for Genzyme, but the French drugmaker may be wiser to stick with smaller, bolt-on acquisitions. Sanofi is trying...
05.07.2010
- Sanofi-Aventis declined to comment on Friday on a Bloomberg report that it was preparing an acquisition of $20 billion or more in the U.S. as shares in the French drugmaker fell...
30.06.2010
- Sanofi-Aventis is to buy U.S. biotech TargeGen, which is developing treatments against blood diseases, for as much as $560 million as part of the French drugmaker's drive to boost...
